PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Oct-2023 MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023 Businesswire
04-Oct-2023 Phastar Net-Zero Target Approved by the Science Based Targets Initiative Phastar
04-Oct-2023 Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio Businesswire
04-Oct-2023 ROME Expands Leadership Team with the Appointment of Industry Veteran Kyle Kuvalanka as Chief Financial Officer and Chief Business Officer Businesswire
04-Oct-2023 Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting Businesswire
04-Oct-2023 Eurofins CDMO Alphora Inc. (Canada) Announces the Launch of its Biologics Initiative focusing on mAbs and Therapeutic Proteins Businesswire
04-Oct-2023 ViroCell expands business development team to support next phase of growth ViroCell
04-Oct-2023 XiltriX North America Announces SOC 2 Type 1 Certification for Enhanced Security and Compliance of Its Monitoring-as-a-Service Solution Newswire
04-Oct-2023 Vacina contra dengue da Takeda recomendada pelo Grupo Consultivo da Organização Mundial da Saúde para introdução em áreas de alta carga e transmissão de dengue em crianças de 6 a 16 anos Businesswire
04-Oct-2023 Takedas Dengue-Impfstoff von der Beratungsgruppe der Weltgesundheitsorganisation zur Einführung in Gebieten mit hoher Dengue-Belastung und -Übertragung bei Kindern im Alter von sechs bis 16 Jahren empfohlen Businesswire
04-Oct-2023 Elixir Medical Completes Submission of DynamX Coronary Bioadaptor System to Japan’s PMDA Agency for Regulatory Approval Businesswire
04-Oct-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
04-Oct-2023 ViroCell Expands Business Development Team to Support Next Phase of Growth Businesswire
04-Oct-2023 Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment Businesswire
04-Oct-2023 Velsera to Showcase Seven Bridges Bioinformatics Platform at BioTechX Europe Businesswire
04-Oct-2023 Majority of Newborn Babies With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Able to Sit Independently After 1 Year of Treatment Businesswire
04-Oct-2023 Le vaccin contre la dengue de Takeda recommandé par le Groupe consultatif de l’OMS pour une mise sur le marché dans des zones à fardeau élevé et de transmission pour les enfants âgés de six à 16 ans Businesswire
04-Oct-2023 Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting Businesswire
04-Oct-2023 Additional Results of POSLUMA® (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO Businesswire
03-Oct-2023 Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years Businesswire